Pub Date : 2025-09-01Epub Date: 2025-04-23DOI: 10.1055/a-2560-3827
Benedikt Becker, Christopher Netsch, Andreas J Gross, Clemens Rosenbaum, Friedrich Otto Hartung, Simon Filmar, Sophia Hook
Anatomical enucleation of the prostate (AEEP) is an established treatment option for benign prostatic hyperplasia (BPH), regardless of prostate size. While advancements in laser technology have significantly improved the enucleation phase, the morcellation process has remained relatively unchanged, with limited innovations in morcellation devices. This study aimed to compare the efficiency of two morcellators in an ex-vivo model: the Piranha morcellator (Richard Wolf GmbH, Knittlingen) and a newly introduced, yet-to-be-commercialized device, the ActiveCut morcellator (Active Fiber Systems GmbH, Jena).The two morcellators were tested in a newly developed ex-vivo model. In both groups, reusable blades were tested ten times at comparable speed settings. For each trial, 60 grams of raw bovine heart tissue were morcellated. The efficiency of the morcellation was then analyzed. Primary endpoints included morcellation efficiency (g/min) and an evaluation of blade deterioration over repeated use. The mean values of continuous variables were compared using a t-test with standard deviation.A total of ten consecutive morcellation trials were conducted with each device. The ActiveCut demonstrated higher morcellation rates at 12.43 g/min, compared to 7.09 g/min with the Piranha morcellator (p<0.05). However, the ActiveCut showed a decline in efficiency over ten trials. In two cases, tissue had to be manually removed from the blade coupling during morcellation, whereas the Piranha morcellator maintained consistent performance without malfunctions.In this ex-vivo study, comparing the ActiveCut and Piranha morcellators, the ActiveCut exhibited higher morcellation efficiency. However, as the ActiveCut has not yet undergone clinical testing, future clinical studies are necessary to assess its safety and potential malfunctions before clinical implementation.
解剖性前列腺摘除(AEEP)是治疗良性前列腺增生(BPH)的常用方法,与前列腺大小无关。虽然激光技术的进步大大改善了去核阶段,但粉碎过程仍然保持相对不变,粉碎设备的创新有限。本研究的目的是在离体模型中比较两种粉碎器的效率:Piranha粉碎器(Richard Wolf GmbH, Knittlingen)和一种新推出的尚未商业化的设备ActiveCut粉碎器(Active Fiber Systems GmbH, Jena)。这两种粉碎剂在新开发的离体模型中进行了测试。在两组中,可重复使用的叶片在相同的速度设置下测试了10次。在每次试验中,将60克生牛心脏组织粉碎。并对粉碎效率进行了分析。主要终点包括粉碎效率(g/min)和反复使用后叶片退化的评估。连续变量的均值比较采用带标准差的t检验。每台设备共进行了10次连续粉碎试验。ActiveCut的粉碎速率为12.43 g/min,而Piranha粉碎机的粉碎速率为7.09 g/min
{"title":"[Ex-vivo Comparative Study on the Morcellation Efficiency of Different Morcellators].","authors":"Benedikt Becker, Christopher Netsch, Andreas J Gross, Clemens Rosenbaum, Friedrich Otto Hartung, Simon Filmar, Sophia Hook","doi":"10.1055/a-2560-3827","DOIUrl":"10.1055/a-2560-3827","url":null,"abstract":"<p><p>Anatomical enucleation of the prostate (AEEP) is an established treatment option for benign prostatic hyperplasia (BPH), regardless of prostate size. While advancements in laser technology have significantly improved the enucleation phase, the morcellation process has remained relatively unchanged, with limited innovations in morcellation devices. This study aimed to compare the efficiency of two morcellators in an ex-vivo model: the Piranha morcellator (Richard Wolf GmbH, Knittlingen) and a newly introduced, yet-to-be-commercialized device, the ActiveCut morcellator (Active Fiber Systems GmbH, Jena).The two morcellators were tested in a newly developed ex-vivo model. In both groups, reusable blades were tested ten times at comparable speed settings. For each trial, 60 grams of raw bovine heart tissue were morcellated. The efficiency of the morcellation was then analyzed. Primary endpoints included morcellation efficiency (g/min) and an evaluation of blade deterioration over repeated use. The mean values of continuous variables were compared using a t-test with standard deviation.A total of ten consecutive morcellation trials were conducted with each device. The ActiveCut demonstrated higher morcellation rates at 12.43 g/min, compared to 7.09 g/min with the Piranha morcellator (p<0.05). However, the ActiveCut showed a decline in efficiency over ten trials. In two cases, tissue had to be manually removed from the blade coupling during morcellation, whereas the Piranha morcellator maintained consistent performance without malfunctions.In this ex-vivo study, comparing the ActiveCut and Piranha morcellators, the ActiveCut exhibited higher morcellation efficiency. However, as the ActiveCut has not yet undergone clinical testing, future clinical studies are necessary to assess its safety and potential malfunctions before clinical implementation.</p>","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":" ","pages":"433-438"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143953540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-07-09DOI: 10.1055/a-2645-6997
Clemens Rosenbaum, Sophia Hook, Benedikt Becker, Christopher Netsch, Simon Filmar
Bladder neck contracture (BNC) is a common complication following surgical treatment of benign prostatic hyperplasia (BPH), with incidence rates varying depending on the therapeutic approach. Numerous techniques for managing BNC have been described in the literature. For the initial presentation of BNC, endoscopic treatment is generally recommended as the first-line therapy. In cases of recurrent BNC, however, open surgical reconstruction, such as YV or T-plasty, is considered the preferred treatment option. Additionally, robot-assisted surgery is increasingly being integrated into the surgical management of BNC. Currently, no standardized treatment protocol exists for this condition. This review provides a systematic overview of bladder neck contracture and the current therapeutic strategies available.
{"title":"[Bladder neck contracture after surgery for benigne prostate hyperplasia].","authors":"Clemens Rosenbaum, Sophia Hook, Benedikt Becker, Christopher Netsch, Simon Filmar","doi":"10.1055/a-2645-6997","DOIUrl":"10.1055/a-2645-6997","url":null,"abstract":"<p><p>Bladder neck contracture (BNC) is a common complication following surgical treatment of benign prostatic hyperplasia (BPH), with incidence rates varying depending on the therapeutic approach. Numerous techniques for managing BNC have been described in the literature. For the initial presentation of BNC, endoscopic treatment is generally recommended as the first-line therapy. In cases of recurrent BNC, however, open surgical reconstruction, such as YV or T-plasty, is considered the preferred treatment option. Additionally, robot-assisted surgery is increasingly being integrated into the surgical management of BNC. Currently, no standardized treatment protocol exists for this condition. This review provides a systematic overview of bladder neck contracture and the current therapeutic strategies available.</p>","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":" ","pages":"451-455"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144599094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2023-11-14DOI: 10.1055/a-2159-1525
Simon Filmar, Andreas Gross, Christopher Netsch, Clemens Rosenbaum, Benedikt Becker
Introduction: Adult hydrocele is a benign enlargement of the scrotum seen in approximately 60/100,000 men >18 years of age. Surgical resection of the hydrocele has been established as the gold standard for the treatment of symptomatic hydroceles. Postoperative complications are common with this surgery. Due to the lack of guidelines for the therapy of hydrocele, treatment is based primarily on clinical experience. The aim of the study was to conduct a randomised study on the influence of drains on complications in hydrocele resection according to von Bergmann.
Material and methods: A total of 60 patients were prospectively randomised into three groups. The groups each received an Easy-Flow drainage, a Cuti-Med Sorbact drainage, or no drainage. Haematoma and swelling, postoperative bleeding, infection, epididymal injury and revision surgery were clinically diagnosed as complications.
Results: A complication was observed in 31.6% (n=19/60) of all patients. The complication rate was 50% (n=10) for the easy-flow drainage, 30% (n=6) for the Cuti-Med-Sorbact and 15% (n=3) for the group without drainage. Overall, a haematoma with swelling was observed most frequently, in 20% (n=12) of the cases. Revision surgery was required in 5% (n=3) of cases. Epididymal injuries were found histologically in 10% (n=6). Comparing the collective with the Easy-Flow drainage with the collective without drainage, the occurrence of complications was observed significantly more frequently in the drainage group (p<0.018). A statistically significant correlation regarding complications between the group of Cuti-Med-Sorbact and no drainage could not be shown (p<0.25).
Conclusions: Hydrocele resection is a complicated procedure. Based on the data presented here, the insertion of a drain is associated with an increased risk of postoperative complications. If the decision to insert a wound drainage is made intraoperatively, the Cuti-Med-Sorbact drainage appears to be associated with fewer complications.
{"title":"[Randomised comparison of different exit strategies in hydrocele resection].","authors":"Simon Filmar, Andreas Gross, Christopher Netsch, Clemens Rosenbaum, Benedikt Becker","doi":"10.1055/a-2159-1525","DOIUrl":"10.1055/a-2159-1525","url":null,"abstract":"<p><strong>Introduction: </strong>Adult hydrocele is a benign enlargement of the scrotum seen in approximately 60/100,000 men >18 years of age. Surgical resection of the hydrocele has been established as the gold standard for the treatment of symptomatic hydroceles. Postoperative complications are common with this surgery. Due to the lack of guidelines for the therapy of hydrocele, treatment is based primarily on clinical experience. The aim of the study was to conduct a randomised study on the influence of drains on complications in hydrocele resection according to von Bergmann.</p><p><strong>Material and methods: </strong>A total of 60 patients were prospectively randomised into three groups. The groups each received an Easy-Flow drainage, a Cuti-Med Sorbact drainage, or no drainage. Haematoma and swelling, postoperative bleeding, infection, epididymal injury and revision surgery were clinically diagnosed as complications.</p><p><strong>Results: </strong>A complication was observed in 31.6% (n=19/60) of all patients. The complication rate was 50% (n=10) for the easy-flow drainage, 30% (n=6) for the Cuti-Med-Sorbact and 15% (n=3) for the group without drainage. Overall, a haematoma with swelling was observed most frequently, in 20% (n=12) of the cases. Revision surgery was required in 5% (n=3) of cases. Epididymal injuries were found histologically in 10% (n=6). Comparing the collective with the Easy-Flow drainage with the collective without drainage, the occurrence of complications was observed significantly more frequently in the drainage group (p<0.018). A statistically significant correlation regarding complications between the group of Cuti-Med-Sorbact and no drainage could not be shown (p<0.25).</p><p><strong>Conclusions: </strong>Hydrocele resection is a complicated procedure. Based on the data presented here, the insertion of a drain is associated with an increased risk of postoperative complications. If the decision to insert a wound drainage is made intraoperatively, the Cuti-Med-Sorbact drainage appears to be associated with fewer complications.</p>","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":" ","pages":"477-483"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"107589972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-06-05DOI: 10.1055/a-2599-8213
Peter Jochen Olbert
Epidemiological data demonstrate a clear association between age, prostatic enlargement, and the associated symptoms. Benign prostatic syndromes usually take a chronic progressive course, and a significant share of BPS patients faced with the decision "conservative vs. surgical treatment" are of advanced age and suffer from numerous comorbidities, which means that the principle of "nihil nocere" must be given special consideration. A benefit-risk assessment must be carried out very carefully both for pharmacological and surgical treatment. Having reviewed the literature, including the relevant guidelines, the author concludes that, if a relevant indication exists, there are hardly any reasons to deny geriatric patients one of the numerous interventional options, perhaps with the exception of a patient population that is already in need of long-term care.
{"title":"[Benign prostatic hyperplasia with bladder emptying disorder in geriatric patients: active (pharmacological or surgical) treatment vs. catheterization].","authors":"Peter Jochen Olbert","doi":"10.1055/a-2599-8213","DOIUrl":"10.1055/a-2599-8213","url":null,"abstract":"<p><p>Epidemiological data demonstrate a clear association between age, prostatic enlargement, and the associated symptoms. Benign prostatic syndromes usually take a chronic progressive course, and a significant share of BPS patients faced with the decision \"conservative vs. surgical treatment\" are of advanced age and suffer from numerous comorbidities, which means that the principle of \"nihil nocere\" must be given special consideration. A benefit-risk assessment must be carried out very carefully both for pharmacological and surgical treatment. Having reviewed the literature, including the relevant guidelines, the author concludes that, if a relevant indication exists, there are hardly any reasons to deny geriatric patients one of the numerous interventional options, perhaps with the exception of a patient population that is already in need of long-term care.</p>","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":" ","pages":"439-444"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144232940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}